3.8 Article

Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars

期刊

JCO GLOBAL ONCOLOGY
卷 6, 期 -, 页码 1461-1471

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/GO.20.00423

关键词

-

类别

资金

  1. Abbott (Inst)
  2. AbbVie (Inst)
  3. Asahi Kasei (Inst)
  4. Astellas Pharma (Inst)
  5. Biogen Japan (Inst)
  6. Celgene (Inst)
  7. Chugai Pharma (Inst)
  8. Covidien Japan (Inst)
  9. Daiichi Sankyo (Inst)
  10. Eisai (Inst)
  11. Lilly Japan (Inst)
  12. GlaxoSmithKline (Inst)
  13. Johnson Johnson (Inst)
  14. Kyowa Hakko Kirin (Inst)
  15. Meiji Seika Pharma (Inst)
  16. Merck Serono (Inst)
  17. MSD (Inst)
  18. Nippon Kayaku (Inst)
  19. Novartis (Inst)
  20. Ono Pharmaceutical (Inst)
  21. Sanofi/Aventis (Inst)
  22. Taiho Pharmaceutical (Inst)
  23. Tsumura (Inst)
  24. Yakult Honsha (Inst)

向作者/读者索取更多资源

PURPOSE In response to the COVID-19 pandemic, the ASCO launched a Global Webinar Series to address various aspects of cancer care during the pandemic. Here we present the lessons learned and recommendations that have emerged from these webinars. METHODS Fifteen international health care experts from different global regions and oncology disciplines participated in one of the six 1-hour webinars to discuss the latest data, share their experiences, and provide recommendations to manage cancer care during the COVID-19 pandemic. These sessions include didactic presentations followed by a moderated discussion and questions from the audience. All recommendations have been transcribed, categorized, and reviewed by the experts, who have also approved the consensus recommendations. RESULTS The summary recommendations are divided into different categories, including risk minimization; care prioritization of patients; health care team management; virtual care; management of patients with cancer undergoing surgical, radiation, and systemic therapy; clinical research; and recovery plans. The recommendations emphasize the protection of patients and health care teams from infections, delivery of timely and appropriate care, reduction of harm from the interruption of care, and preparation to handle a surge of new COVID-19 cases, complications, or comorbidities thereof. CONCLUSION The recommendations from the ASCO Global Webinar Series may guide practicing oncologists to manage their patients during the ongoing pandemic and help organizations recover from the crisis. Implementation of these recommendations may improve understanding of how COVID-19 has affected cancer care and increase readiness to manage the current and any future outbreaks effectively. (c) 2020 by American Society of Clinical Oncology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据